| Authors: |
Flores TF; Department of Medicine, Division of Cancer Survivorship and Screening, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA., Tonorezos ES; Office of Cancer Survivorship, National Cancer Institute Division of Cancer Control and Population Sciences, Bethesda, Maryland, USA., Bhatia S; Department of Medicine, Division of Hematology-Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington, USA., Brahmer JR; Department of Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Cappelli LC; Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Cooper M; ImmunoOncology Branch, Developmental Therapy Program, National Cancer Institute Division of Cancer Treatment and Diagnosis, Bethesda, Maryland, USA., Davies M; Smilow Cancer Hospital at Yale-New Haven, Yale Cancer Center, New Haven, Connecticut, USA., Guild S; AIM at Melanoma, Sacramento, California, USA., Gunturu K; Hartford HealthCare Cancer Institute, Hartford, Connecticut, USA., Haanen JBAG; Netherlands Cancer Institute, Amsterdam, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands.; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Lacouture ME; Department of Medicine, Dermatology Division, NYU Grossman Long Island School of Medicine, Mineola, New York, USA., Leidner R; EACRI, Providence Cancer Institute, Portland, Oregon, USA., Mitchell S; Outcomes Research Branch, National Cancer Institute Healthcare Delivery Research Program, Rockville, Maryland, USA., Moledina DG; Department of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, Connecticut, USA., Moslehi J; Section of Cardio-Oncology and Immunology, Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, USA., Naidoo J; Department of Oncology, Beaumont Hospital, Dublin, Leinster, Ireland.; RCSI University of Medicine and Health Sciences, Dublin, Leinster, Ireland., Obeid M; Department of Medicine, LCIT center, Service of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Postow M; Melanoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Reid ME; Cancer Screening and Survivorship, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Santomasso BD; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Neurology, Weill Cornell Medical College, New York, New York, USA., Schadendorf D; Department of Dermatology and Comprehensive Cancer Cancer Center (Westdeutsches Tumorzentrum), University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases (NCT-West), Essen, Germany.; Research Alliance Ruhr, Research Center One Health, University of Duisburg-Essen, Essen, Germany., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Sullivan RJ; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Walunas T; Center for Health Information Partnerships, Institute for Artificial Intelligence in Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Wang Y; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.; Università degli studi di Napoli Federico II, Napoli, Italy., Ernstoff MS; Section of Oncology, Dartmouth Health, Lebanon, New Hampshire, USA marc.s.ernstoff@hitchcock.org. |
